Literature DB >> 17387006

How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study.

E Mannucci1, M Monami, C M Rotella.   

Abstract

BACKGROUND AND AIMS: Factor analysis can be used as a basis for the determination of diagnostic criteria for the metabolic syndrome (MS). This approach can be used as a basis for the determination of diagnostic criteria for MS. METHODS AND
RESULTS: Exploratory factor analysis of Adult Treatment Panel (ATP)-III and International Diabetes Federation (IDF) criteria for MS, entered as dichotomic variables, was performed on 2945 patients enrolled in a screening programme for diabetes. The ability of calculated factors to identify patients with MS-related conditions (glucose intolerance, hyperuricaemia, and elevation of alanine aminotransferase; ALT) was assessed through Receiver Operator Characteristics (ROC) curve analysis. Alternative sets of criteria based on ATP-III and IDF definitions of MS were also assessed. A two-factor structure was found for both ATP-III and IDF criteria. Factor 1 (associated with fasting hyperglycaemia, hypertension, and elevated waist circumference) was capable of identifying subjects with MS-related conditions to a greater extent than factor 2 (low HDL-cholesterol and hypertriglyceridaemia). When a composite variable (low HDL-cholesterol and/or hypertriglyceridaemia) was used for dislipidaemia, a single factor structure was obtained both for ATP-III and IDF definitions; this factor structure was retained when hyperuricaemia was added as a fifth component of MS. Such a modified definition of MS was not inferior to original ATP-III and IDF criteria in the identification of subjects with glucose intolerance and elevated ALT.
CONCLUSIONS: A modification of current ATP-III or IDF criteria is necessary in order to obtain a single-factor structure. Alternative definitions of MS, including additional features, such as hyperuricaemia, can maintain a monofactorial structure, and an association with related conditions not inferior to that of original criteria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387006     DOI: 10.1016/j.numecd.2006.09.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  10 in total

1.  Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis.

Authors:  Alireza Esteghamati; Ali Zandieh; Omid Khalilzadeh; Afsaneh Morteza; Alipasha Meysamie; Manouchehr Nakhjavani; Mohammad Mehdi Gouya
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

2.  Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome.

Authors:  S K Rahamon; U A Fabian; M A Charles-Davies; J A Olaniyi; A A Fasanmade; K S Akinlade; O E Oyewole; M O Owolabi; J R Adebusuyi; O O Hassan; B M Ajobo; M O Ebesunun; K Adigun; O O Popoola; W Omiyale; O G Arinola; E O Agbedana
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

3.  Metabolic syndrome after bariatric surgery. Results depending on the technique performed.

Authors:  Jose Antonio Gracia-Solanas; M Elia; V Aguilella; J M Ramirez; J Martínez; M A Bielsa; M Martínez
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

4.  Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population.

Authors:  Alireza Esteghamati; Ali Zandieh; Omid Khalilzadeh; Alipasha Meysamie; Haleh Ashraf
Journal:  Diabetol Metab Syndr       Date:  2010-06-08       Impact factor: 3.320

5.  The structure of metabolic syndrome components across follow-up survey from childhood to adolescence.

Authors:  Adeleh Bahar; Firoozeh Hosseini Esfahani; Mohammad Asghari Jafarabadi; Yadollah Mehrabi; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

6.  A comparison of different approaches to unravel the latent structure within metabolic syndrome.

Authors:  Andrew Woolston; Yu-Kang Tu; Paul D Baxter; Mark S Gilthorpe
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  Hemoglobin concentration is associated with the incidence of metabolic syndrome.

Authors:  Sunyue He; Hongxia Gu; Jie Yang; Qing Su; Xiaoyong Li; Li Qin
Journal:  BMC Endocr Disord       Date:  2021-03-19       Impact factor: 2.763

8.  Bisphenol A and Metabolic Syndrome: Results from NHANES.

Authors:  Srinivas Teppala; Suresh Madhavan; Anoop Shankar
Journal:  Int J Endocrinol       Date:  2012-11-28       Impact factor: 3.257

9.  The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil.

Authors:  Andrea M Isidori; Giovanni Corona; Antonio Aversa; Daniele Gianfrilli; Emmanuele A Jannini; Carlo Foresta; Mario Maggi; Andrea Lenzi
Journal:  Int J Endocrinol       Date:  2014-05-15       Impact factor: 3.257

10.  Factor analysis for the clustering of cardiometabolic risk factors and sedentary behavior, a cross-sectional study.

Authors:  Tsung-Ying Tsai; Pai-Feng Hsu; Chung-Chi Lin; Yuan-Jen Wang; Yaw-Zon Ding; Teh-Ling Liou; Ying-Wen Wang; Shao-Sung Huang; Wan-Leong Chan; Shing-Jong Lin; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.